Vacino Biotech focuses on innovations for HLA-peptide based vaccine (9-mer peptide), nucleic acid medicine (microRNA) and brain delivery technology (targeting peptide) for the indication of infectious disease, neurodegenerative disease and oncology. Core products: Oral universal COVID vaccine against SARS-CoV-2 variants A microRNA-based anti-neuroinflammation therapeutics A brain shuttled anti-Her2 antibody for treating the peripheral and intracranial tumors. An oral bioavailable brain-targeting LNP for delivering the oligonucleotide and large molecule therapeutics Show less Description (NOTE: Given time constraints & strategic priorities, we will not be meeting with CMOs, CROs, service companies, etc. at the meeting) Founded in July 2020, Vacino Biotech is committed to the development of novel nucleic acid drugs and universal vaccines. With the self-developed next-generation vaccine design SED technology, we have invested in the development of COVID-19 T-cell vaccine products to solve the situation of rapid mutation of the new coronavirus variants. In addition, it has invested in the development of nucleic acid drugs for the treatment of Alzheimer’s disease and a cutting-edge efficient brain delivery technology to increase the content of brain treatment drugs and prevent the occurrence of diseases at an early stage. ● Core products and platform technology Oral universal COVID-19 vaccine: VACINO-CO is a novel oral universal antigen vaccine designed to protect against most COVID-19 viruses and related variants. Through the activation of T cells, it can eliminate virus-infected cells, which can effectively inhibit recurrence and the phenomenon of seroconversion. The innovative and convenient oral dosage form can be applied to the elderly and children in vulnerable groups to obtain safer and effective immunity, safe and effective immune protection of the population. It is currently about to enter human clinical trials. MicroRNA-based Alzheimer’s Disease Drug Developments: Patented Vacino-ADmir is a microRNA-based drug that inhibits neuroinflammation through the PD1/PDL1 mechanism associated with inflammation and can be treated from the source of the disease, which is different from the symptomatic treatment on the market. It can be applied to dementia and neuroinflammation-related diseases. GMP manufacturing is currently underway. High-Performance Brain Delivery Platform Technology: The patented Vacino-BT target peptide can be co-transported by binding to transferrin receptors through transcytosis, with a brain delivery rate of more than 20 % a 1-hour post-injection, which is far superior to other brain delivery technologies on the market. At present, it has been successfully applied to antibodies and lipid nanoparticles. GoBrain LNP: Based VBT technology, we developed VBT-lipid conjugates that can enable LNP having brain targeting capability. HerBrain and eHerbrain platform: Based on VBT technology, we developed chemically modified anti-Her2 antibody and novel DNA-engineered anti-Her2 antibody, which allows brain shuttle capability and tissue penetration.
V-CHECK, Inc.
V-CHECK is dedicated to provide reliable and cost-effective in vitro diagnostic products for women’s diseases, particularly for those without sensitive biomarkers for early diagnosis.
UWICOM Co., Ltd.
UWICOM is a healthcare technology company based in South Korea, specializing in developing innovative assistive listening devices to improve communication and quality of life for the elderly. Certified with KC, CE, FCC, and TELEC, and supported by registered patents, our solutions meet international safety and performance standards.
Utah Governor’s Office of Economic Opportunity
GOEO supports Utah entrepreneurs and businesses. We work to retain and recruit companies and bring more high-paying jobs to Utah. In addition, we work with industries, Utah regions, communities, and nonprofits to implement strategic economic development plans and reinforce Utah’s already diverse, prosperous economy. | The office supports Utah entrepreneurs and businesses. We work to retain and recruit companies and bring more high-paying jobs to Utah. In addition, we work with industries, Utah regions, communities, and nonprofits to implement strategic economic development plans and reinforce Utah’s already diverse, prosperous economy.
UST Global
Since 1999, UST has partnered with leading companies to drive impactful transformation. Through digital solutions, platforms, engineering, R&D, products, and an innovation ecosystem, we turn challenges into disruptive solutions. With 30,000+ employees in 30+ countries, we deliver measurable value, infusing innovation and agility into our clients’ organizations. Visit us at www.UST.com.
Ustation Inc.
Ustation Inc. is a specialist in developing and manufacturing AIoT medical devices (portable electrocardiographs and blood pressure monitors) and biosensors. We are reinforcing our competitive edge in instrumentation and medical device-linked data platform services.
Urevo Wellness US Co., Ltd
UREVO is building a 3*8 hours Al-powered wellness ecosystem, an intelligent App integrated with Google’s Gemini Al model, integrating your family fitness training, health management, recovery support, healthy sleep, wellness record tracking, and even with your pet wellness.Sm
UNTRACKED Inc
UNTRACKED is a Japanese university spin-off startup. It has developed the world’s first technology to evaluate fall risk from both physical and sensory function perspectives. The solution enables simple at-home assessment and automatically delivers personalized exercise games based on individual evaluation results for healthy aging.
UnoVins Inc.
UnoVins develops and commercializes the UNOCARE platform, which analyzes stress and autonomic nervous system activity using PPG and EEG signals. Our wellness solutions quantify brain and autonomic health, provide intuitive insights, and deliver personalized wellness content for sustainable daily care.